Drug May Offer Lasting Cure for Hormone Hypertension
Drug May Offer Lasting Cure for Hormone Hypertension
Drug May Offer Lasting Cure for Hormone Hypertension
Key points
اہم نکات
मुख्य बातें
- A drug may offer a lasting cure for a common hormonal cause of high blood pressure, even after patients stop taking it, a small study has found.
- Researchers at Queen Mary University of London followed 14 people with primary aldosteronism, a condition in which benign nodules on the adrenal glands produce too much of the hormone aldosterone, who took the drug baxdrostat for six to 12 months.
- A key marker of excess aldosterone stayed about 99 percent below its starting level, average systolic blood pressure fell by about 25 mmHg, and nearly one in four patients had normal blood pressure without any medication up to two years later.
- A drug may offer a lasting cure for a common hormonal cause of high blood pressure, even after patients stop taking it, a small study has found.
- Researchers at Queen Mary University of London followed 14 people with primary aldosteronism, a condition in which benign nodules on the adrenal glands produce too much of the hormone aldosterone, who took the drug baxdrostat for six to 12 months.
- A key marker of excess aldosterone stayed about 99 percent below its starting level, average systolic blood pressure fell by about 25 mmHg, and nearly one in four patients had normal blood pressure without any medication up to two years later.
- A drug may offer a lasting cure for a common hormonal cause of high blood pressure, even after patients stop taking it, a small study has found.
- Researchers at Queen Mary University of London followed 14 people with primary aldosteronism, a condition in which benign nodules on the adrenal glands produce too much of the hormone aldosterone, who took the drug baxdrostat for six to 12 months.
- A key marker of excess aldosterone stayed about 99 percent below its starting level, average systolic blood pressure fell by about 25 mmHg, and nearly one in four patients had normal blood pressure without any medication up to two years later.
A drug may offer a lasting cure for a common hormonal cause of high blood pressure, even after patients stop taking it, a small study has found. Researchers at Queen Mary University of London followed 14 people with primary aldosteronism, a condition in which benign nodules on the adrenal glands produce too much of the hormone aldosterone, who took the drug baxdrostat for six to 12 months. A key marker of excess aldosterone stayed about 99 percent below its starting level, average systolic blood pressure fell by about 25 mmHg, and nearly one in four patients had normal blood pressure without any medication up to two years later. The results, published in the New England Journal of Medicine, are early: the study was small and had no control group, so a larger trial called ELIXIR will now test whether a short course of the drug can truly cure the condition.
A drug may offer a lasting cure for a common hormonal cause of high blood pressure, even after patients stop taking it, a small study has found. Researchers at Queen Mary University of London followed 14 people with primary aldosteronism, a condition in which benign nodules on the adrenal glands produce too much of the hormone aldosterone, who took the drug baxdrostat for six to 12 months. A key marker of excess aldosterone stayed about 99 percent below its starting level, average systolic blood pressure fell by about 25 mmHg, and nearly one in four patients had normal blood pressure without any medication up to two years later. The results, published in the New England Journal of Medicine, are early: the study was small and had no control group, so a larger trial called ELIXIR will now test whether a short course of the drug can truly cure the condition.
A drug may offer a lasting cure for a common hormonal cause of high blood pressure, even after patients stop taking it, a small study has found. Researchers at Queen Mary University of London followed 14 people with primary aldosteronism, a condition in which benign nodules on the adrenal glands produce too much of the hormone aldosterone, who took the drug baxdrostat for six to 12 months. A key marker of excess aldosterone stayed about 99 percent below its starting level, average systolic blood pressure fell by about 25 mmHg, and nearly one in four patients had normal blood pressure without any medication up to two years later. The results, published in the New England Journal of Medicine, are early: the study was small and had no control group, so a larger trial called ELIXIR will now test whether a short course of the drug can truly cure the condition.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।